Altium Capital Management LP Vera Therapeutics, Inc. Transaction History
Altium Capital Management LP
- $301 Million
- Q4 2024
A detailed history of Altium Capital Management LP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Altium Capital Management LP holds 432,000 shares of VERA stock, worth $12.7 Million. This represents 6.07% of its overall portfolio holdings.
Number of Shares
432,000
Previous 684,000
36.84%
Holding current value
$12.7 Million
Previous $30.2 Million
39.56%
% of portfolio
6.07%
Previous 10.66%
Shares
8 transactions
Others Institutions Holding VERA
# of Institutions
193Shares Held
63.9MCall Options Held
68.1KPut Options Held
88.6K-
Avoro Capital Advisors LLC New York, NY5.61MShares$165 Million3.46% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.38MShares$129 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$98.2 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$87.1 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.95MShares$86.7 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $795M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...